https://pdl122c3-learning.dako.com/
The Dako PD-L1 IHC 22C3 pharmDx Interpretation Training Program
pd l1dakoihc22c3pharmdx
https://www.agilent.com/about/newsroom/presrel/2022/15jun-ca22021.html
Agilent Receives MFDS Approval in South Korea for Companion Diagnostic PD-L1 IHC 22C3 pharmDx on...
https://www.businesswire.com/news/home/20260326909115/en/Agilent-Receives-FDA-Approval-for-PD-L1-IHC-22C3-pharmDx-in-Esophageal-or-Gastroesophageal-Junction-GEJ-Carcinoma
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction...
Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK...
https://www.marketscreener.com/news/agilent-technologies-inc-receives-fda-approval-for-pd-l1-ihc-22c3-pharmdx-in-esophageal-or-gastroe-ce7e51dbda88f427
Agilent Technologies, Inc. Receives FDA Approval For PD-L1 IHC 22C3 PharmDx In Esophageal Or...
Mar 26, 2026 - Agilent Technologies Inc. received U.S. Food and Drug Administration approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in...